Tuberculous lymphadenitis in Northern Ethiopia: in a public health and microbiological perspectives

PLoS One. 2013 Dec 9;8(12):e81918. doi: 10.1371/journal.pone.0081918. eCollection 2013.

Abstract

Background: The actual burden and causative agent of tuberculous lymphadenitis (TBLN) cases is not well known due to lack of strong surveillance system and diagnostic facilities in Ethiopia. This study was conducted to determine the prevalence of TBLN, its causative agent and risk factors for acquiring this infection.

Methods: A cross-sectional study was conducted from April to May 2012 at four main hospitals and one diagnostic clinic located in northern Ethiopia. Fine needle aspirates (FNAs) from TBLN suspects were taken for acid fast bacilli (AFB) microscopy, culture and molecular typing.

Results: Among 437 aspirates, culture yielded AFB in 226 (51.7%) of cases. Sixty one culture negative cases (30.5% of 200 cases) were positive by Xpert MTB/RIF test. Moreover, a rifampicin resistant AFB was detected from culture negative cases. The overall prevalence of FNAs positive TBLN cases was 65.8 %. The BacT/AlerT 3D system proved to be a more rapid method with higher recovery rate than Lowenstein-Jensen (L-J) and/or Gottsacker media (P<0.0001). Molecular typing identified all culture positive isolates as M.tuberculosis. The main risk factors for TBLN were pediatric age (OR 2.8, 95% CI, 1.09- 7.05) and cough (OR 2, 95%CI, 1.09-3.7).

Conclusions: The results of this study revealed a high prevalence of TBLN in the study sites and that pediatric age and cough are key predictors of the disease. TBLN is an important public health problem that needs to be addressed in the area. It is important to note that MDR strains of TB could be involved and aetiological confirmation and drug sensitivity testing of TBLN isolates should be expanded. Further studies on the M.tuberculosis lineages, circulating strains and transmission dynamics, are recommended.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Typing Techniques
  • Child
  • Child, Preschool
  • Cough / pathology
  • Cross-Sectional Studies
  • Ethiopia / epidemiology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Lymph Nodes / microbiology*
  • Lymph Nodes / pathology
  • Middle Aged
  • Mycobacterium tuberculosis / classification
  • Mycobacterium tuberculosis / isolation & purification*
  • Prevalence
  • Rifampin / therapeutic use
  • Tuberculosis, Lymph Node / drug therapy
  • Tuberculosis, Lymph Node / epidemiology*
  • Tuberculosis, Lymph Node / microbiology
  • Tuberculosis, Lymph Node / pathology
  • beta-Lactam Resistance*

Substances

  • Anti-Bacterial Agents
  • Rifampin

Grants and funding

The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0315883), the Institute of Medical Microbiology and Epidemiology of Infectious diseases, University hospital Leipzig, Germany, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany, the German academic Exchange (DAAD) and University of Bahir Dar, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.